Literature DB >> 9743612

Decline in total T cell count is associated with onset of AIDS, independent of CD4(+) lymphocyte count: implications for AIDS pathogenesis.

J B Margolick1, A D Donnenberg, C Chu, M R O'Gorman, J V Giorgi, A Muñoz.   

Abstract

We previously reported that blind T cell homeostasis, in which the total T cell count is maintained but the CD4(+) and CD8(+) subset composition of the T cells can vary, fails approximately 1.5 to 2.5 years before the onset of AIDS. The present study was premised on the hypothesis that if failure of T cell homeostasis (i.e., a decline in total T cell counts) is important in the pathogenesis of AIDS, it should be a significant predictor of AIDS after controlling for the CD4(+) lymphocyte count. Data from 1556 homosexual men with sufficient sequential T cell subset measurements were evaluated, representing 11,988 person-visits in men with known clinical outcomes over a period of more than 10 years. Using regression models that incorporated CD4(+) lymphocyte count and HIV-related symptoms (fever, thrush), it was determined that a yearly decline of more than 300 T cells/microliter of peripheral blood was an independent predictor of the onset of AIDS for subjects with CD4(+) lymphocyte counts of <500 cells/microliter. The results support an important role for failure of T cell homeostasis in the pathogenesis of AIDS. Copyright 1998 Academic Press.

Entities:  

Mesh:

Year:  1998        PMID: 9743612     DOI: 10.1006/clin.1998.4577

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  9 in total

1.  Neural networks morbidity and mortality modeling during loss of HIV T-cell homeostasis.

Authors:  G E Hatzakis; C M Tsoukas
Journal:  Proc AMIA Symp       Date:  2002

2.  Longitudinal assessment of de novo T cell production in relation to HIV-associated T cell homeostasis failure.

Authors:  Pratip K Chattopadhyay; Daniel C Douek; Stephen J Gange; Karen R Chadwick; Marc Hellerstein; Joseph B Margolick
Journal:  AIDS Res Hum Retroviruses       Date:  2006-06       Impact factor: 2.205

3.  Impact of opportunistic Mycobacterium tuberculosis infection on the phenotype of peripheral blood T cells of AIDS patients.

Authors:  Germán Bernal-Fernández; Carlos Hermida; Patricia Espinosa-Cueto; Ana Cristina Cubilla-Tejeda; Jesús Fidel Salazar-González; Librado Ortiz-Ortiz; Rosario Leyva-Meza; Hugo Diaz-Silvestre; Raul Mancilla
Journal:  J Clin Lab Anal       Date:  2006       Impact factor: 2.352

4.  Decline of CD3-positive T-cell counts by 6 months of age is associated with rapid disease progression in HIV-1--infected infants.

Authors:  J Chinen; K A Easley; H Mendez; W T Shearer
Journal:  J Allergy Clin Immunol       Date:  2001-08       Impact factor: 10.793

5.  Emergence and persistence of CXCR4-tropic HIV-1 in a population of men from the multicenter AIDS cohort study.

Authors:  James C Shepherd; Lisa P Jacobson; Wei Qiao; Beth D Jamieson; John P Phair; Paolo Piazza; Thomas C Quinn; Joseph B Margolick
Journal:  J Infect Dis       Date:  2008-10-15       Impact factor: 5.226

6.  Availability of activated CD4+ T cells dictates the level of viremia in naturally SIV-infected sooty mangabeys.

Authors:  Nichole R Klatt; Francois Villinger; Pavel Bostik; Shari N Gordon; Lara Pereira; Jessica C Engram; Ann Mayne; Richard M Dunham; Benton Lawson; Sarah J Ratcliffe; Donald L Sodora; James Else; Keith Reimann; Silvija I Staprans; Ashley T Haase; Jacob D Estes; Guido Silvestri; Aftab A Ansari
Journal:  J Clin Invest       Date:  2008-06       Impact factor: 14.808

Review 7.  CD4 immunophenotyping in HIV infection.

Authors:  David Barnett; Brooke Walker; Alan Landay; Thomas N Denny
Journal:  Nat Rev Microbiol       Date:  2008-11       Impact factor: 60.633

Review 8.  Point of Care Diagnostics for HIV in Resource Limited Settings: An Overview.

Authors:  Sello Lebohang Manoto; Masixole Lugongolo; Ureshnie Govender; Patience Mthunzi-Kufa
Journal:  Medicina (Kaunas)       Date:  2018-03-13       Impact factor: 2.430

9.  Associating changes in the immune system with clinical diseases for interpretation in risk assessment.

Authors:  Michael I Luster; Dori R Germolec; Christine G Parks; Laura Blaciforti; Michael Kashon; Robert Luebke
Journal:  Curr Protoc Toxicol       Date:  2004
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.